We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCFT icon
2301
MasterCraft Boat Holdings
MCFT
$600M
$134K ﹤0.01%
5,356
LEU icon
2302
Centrus Energy
LEU
$3.69B
$134K ﹤0.01%
+3,474
New +$96.4K
EZPW icon
2303
Ezcorp Inc
EZPW
$1.78B
$134K ﹤0.01%
+17,725
New +$114K
SRI icon
2304
Stoneridge
SRI
$197M
$133K ﹤0.01%
6,543
-4,135
-39% -$102K
GTHX
2305
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$133K ﹤0.01%
9,940
-5,754
-37% -$93.8K
RCKY icon
2306
Rocky Brands
RCKY
$356M
$133K ﹤0.01%
2,801
MLCO icon
2307
Melco Resorts & Entertainment
MLCO
$2.14B
$133K ﹤0.01%
13,000
DSKE
2308
DELISTED
Daseke, Inc. Common Stock
DSKE
$133K ﹤0.01%
+14,445
New +$120K
TRC icon
2309
Tejon Ranch
TRC
$441M
$133K ﹤0.01%
+7,461
New +$133K
NVEC icon
2310
NVE Corp
NVEC
$591M
$132K ﹤0.01%
2,070
PRVB
2311
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$132K ﹤0.01%
20,685
+12,586
+155% +$80.9K
VERU icon
2312
Veru
VERU
$46.7M
$132K ﹤0.01%
1,552
-935
-38% -$74.2K
SPPI
2313
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$132K ﹤0.01%
60,545
+29,725
+96% +$81.2K
WEBR
2314
DELISTED
Weber Inc.
WEBR
$132K ﹤0.01%
+7,501
New +$120K
THR
2315
DELISTED
Thermon Group Holdings
THR
$132K ﹤0.01%
7,621
-5,178
-40% -$86.1K
BRBS icon
2316
Blue Ridge Bankshares
BRBS
$339M
$131K ﹤0.01%
+7,472
New +$130K
FXLV
2317
DELISTED
F45 Training Holdings Inc.
FXLV
$131K ﹤0.01%
+8,740
New +$128K
FOSL icon
2318
Fossil Group
FOSL
$311M
$131K ﹤0.01%
11,026
-6,502
-37% -$84.1K
OSBC icon
2319
Old Second Bancorp
OSBC
$1.31B
$131K ﹤0.01%
9,998
+6,409
+179% +$76.9K
REKR icon
2320
Rekor Systems
REKR
$94M
$131K ﹤0.01%
+11,364
New +$103K
IMVT icon
2321
Immunovant
IMVT
$8.8B
$130K ﹤0.01%
15,009
+10,800
+257% +$97.4K
RYZ
2322
Ryerson Holding Corp
RYZ
$1.5B
$130K ﹤0.01%
+5,848
New +$115K
FOR icon
2323
Forestar Group
FOR
$1.49B
$130K ﹤0.01%
6,983
VOR icon
2324
Vor Biopharma
VOR
$1.32B
$130K ﹤0.01%
+413
New +$123K
PRLD icon
2325
Prelude Therapeutics
PRLD
$457M
$130K ﹤0.01%
4,148

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.